Literature DB >> 29632250

Comment on "Type I CD20 Antibodies Recruit the B Cell Receptor for Complement-Dependent Lysis of Malignant B Cells".

Mitchell Evers1, Elizabeth Kruse2, Firas Hamdan1, Robert-Jan Lebbink2, Jeanette H W Leusen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29632250     DOI： 10.4049/jimmunol.1800087

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  2 in total

1.  The selection of variable regions affects effector mechanisms of IgA antibodies against CD20.

Authors:  Mitchell Evers; Thies Rösner; Anna Dünkel; J H Marco Jansen; Niklas Baumann; Toine Ten Broeke; Maaike Nederend; Klara Eichholz; Katja Klausz; Karli Reiding; Denis M Schewe; Christian Kellner; Matthias Peipp; Jeanette H W Leusen; Thomas Valerius
Journal:  Blood Adv       Date:  2021-10-12

2.  Novel chimerized IgA CD20 antibodies: Improving neutrophil activation against CD20-positive malignancies.

Authors:  Mitchell Evers; Toine Ten Broeke; J H Marco Jansen; Maaike Nederend; Firas Hamdan; Karli R Reiding; Saskia Meyer; Petra Moerer; Iris Brinkman; Thies Rösner; Robert Jan Lebbink; Thomas Valerius; Jeanette H W Leusen
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.